PE20010382A1 - Forma cristalina iii de la n-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamida - Google Patents
Forma cristalina iii de la n-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamidaInfo
- Publication number
- PE20010382A1 PE20010382A1 PE2000000729A PE0007292000A PE20010382A1 PE 20010382 A1 PE20010382 A1 PE 20010382A1 PE 2000000729 A PE2000000729 A PE 2000000729A PE 0007292000 A PE0007292000 A PE 0007292000A PE 20010382 A1 PE20010382 A1 PE 20010382A1
- Authority
- PE
- Peru
- Prior art keywords
- iii
- dimethylaminonaphthalen
- sulfonylamine
- dimethylpropionamide
- hydroxy
- Prior art date
Links
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title abstract 2
- TYNBFJJKZPTRKS-UHFFFAOYSA-N dansyl amide Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(N)(=O)=O TYNBFJJKZPTRKS-UHFFFAOYSA-N 0.000 title abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 238000001069 Raman spectroscopy Methods 0.000 abstract 1
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A LA FORMA CRISTALINA III DE N-(4-(5-DIMETILAMINONAFTALEN-1-SULFONILAMINO)FENIL)-3-HIDROXI-2,2-DIMETILPROPIONAMIDA (DNSP) DE FORMULA I QUE SE CARACTERIZA POR: i)PUNTO DE FUSION DE 140°C, ii)VALORES DE DIFRACCION DE RAYOS X; iii)ESPECTRO RAMAN. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA OBTENCION DE LA FORMA CRISTALINA III DE DNSP CARACTERIZADO PORQUE SE SUSPENDE LA FORMA CRISTALINA I DE DNSP EN AGUA Y/O DISOLVENTES ORGANICOS INERTES A TEMPERATURAS DE 0°C-60°C HASTA LA TRANSFORMACION CUANTITATIVA A LA FORMA CRISTALINA III. LA FORMA CRISTALINA III DE LA N-(4-(5-DIMETILAMINONAFTALEN-1-SULFONILAMINO)FENIL-3-HIDROXI-2,2-DIMETILPROPIONAMIDA PUEDE SER UTIL PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES CAUSADAS POR CITOMEGALOVIRUS HUMANO (HCMV) EN PACIENTES CON SIDA, CON TRASPLANTES DE MEDULA Y ORGANOS, EN RECIEN NACIDOS Y NINOS PEQUENOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19934295A DE19934295A1 (de) | 1999-07-21 | 1999-07-21 | Kristallmodifikation III von N-(4-(5-Dimethylamino-naphthalin-1-sulfonyl-amino)-phenyl)-3-hydroxy-2,2-dimethyl-propionamid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010382A1 true PE20010382A1 (es) | 2001-06-11 |
Family
ID=7915608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000729A PE20010382A1 (es) | 1999-07-21 | 2000-07-20 | Forma cristalina iii de la n-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamida |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR024797A1 (es) |
| AU (1) | AU6562600A (es) |
| CO (1) | CO5180571A1 (es) |
| DE (1) | DE19934295A1 (es) |
| GT (1) | GT200000114A (es) |
| PE (1) | PE20010382A1 (es) |
| UY (1) | UY26251A1 (es) |
| WO (1) | WO2001007404A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6780794B2 (en) | 2000-01-20 | 2004-08-24 | Honeywell International Inc. | Methods of bonding physical vapor deposition target materials to backing plate materials |
| US6698647B1 (en) | 2000-03-10 | 2004-03-02 | Honeywell International Inc. | Aluminum-comprising target/backing plate structures |
| US7371906B2 (en) * | 2004-08-24 | 2008-05-13 | Eastman Kodak Company | Process for photo-oxidative stability improvements |
| EP2481540B1 (de) | 2011-01-28 | 2017-11-01 | Schelling Anlagenbau GmbH | Einrichtung zum Zersägen von zumindest zwei platten- oder plattenstapelförmigen Werkstücken |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20000532A2 (en) * | 1998-01-23 | 2001-02-28 | Bayer Ag | Novel naphthyl-substituted and anilide-substituted sulfonamides |
-
1999
- 1999-07-21 DE DE19934295A patent/DE19934295A1/de not_active Withdrawn
-
2000
- 2000-07-10 AU AU65626/00A patent/AU6562600A/en not_active Abandoned
- 2000-07-10 GT GT200000114A patent/GT200000114A/es unknown
- 2000-07-10 WO PCT/EP2000/006516 patent/WO2001007404A1/de not_active Ceased
- 2000-07-19 AR ARP000103713A patent/AR024797A1/es unknown
- 2000-07-19 UY UY26251A patent/UY26251A1/es not_active Application Discontinuation
- 2000-07-19 CO CO00054502A patent/CO5180571A1/es not_active Application Discontinuation
- 2000-07-20 PE PE2000000729A patent/PE20010382A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001007404A1 (de) | 2001-02-01 |
| CO5180571A1 (es) | 2002-07-30 |
| DE19934295A1 (de) | 2001-01-25 |
| AR024797A1 (es) | 2002-10-23 |
| GT200000114A (es) | 2002-01-01 |
| UY26251A1 (es) | 2001-01-31 |
| AU6562600A (en) | 2001-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0944617T3 (da) | Krystaller af benzimidazolderivater og deres fremstilling | |
| DE60236600D1 (de) | Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung | |
| AR044743A1 (es) | Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos, | |
| TR200000595T2 (tr) | 2,3-Diaril-pirazolo[1,5-B]piridazinler türevleri, bunların hazırlanması ve bunların siklooksijenaz 2 (COX-2) inhibitörleri olarak kullanılması. | |
| PE20030735A1 (es) | Derivados de benzotiazol | |
| NO20050418L (no) | Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet | |
| NO166129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-9h-pyrido (3,4-b)indoler. | |
| ATE87308T1 (de) | 3-aryluracile zur unkrautbekaempfung. | |
| CO5670350A2 (es) | Proceso para preparar derivados de acido 5-(1,3-oxazol- 2-il) benzoico | |
| GR79414B (es) | ||
| SE9701304D0 (sv) | Compounds | |
| ES2150808T3 (es) | Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico. | |
| DE60311869D1 (de) | Kristalline cefdinirsalze | |
| PE20010382A1 (es) | Forma cristalina iii de la n-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamida | |
| DE3072187D1 (de) | Mittel zur regulierung des pflanzenwachstums, deren herstellung und deren verwendung. | |
| NO20074622L (no) | Metabolitter for NK-1 antagonister for brekninger | |
| IL166359A0 (en) | 3-heterocyclyl substituted benzoic acid derivatives | |
| ID26210A (id) | Proses pemurnian turunan sefalosporin | |
| ES462092A1 (es) | Procedimiento para la obtencion de n-aril-(n'alquil y n'-ci-cloalquil)-tioureas. | |
| ATE147380T1 (de) | Herbizide sulfonylharnstoffe, verfahren zur herstellung und ihre verwendung | |
| ES555820A0 (es) | Procedimiento para la obtencion de 1-aril-5-alcoxiiminoalquilamino-pirazoles | |
| GR3001708T3 (en) | 1-phenylimidazole-carbon acid amides, process for their preparation and their use as growth regulators | |
| AR055583A1 (es) | Uso de fenilsemicarbazonas para tratamiento de semillas | |
| ES2128572T3 (es) | Utilizacion de los derivados de cefem como agentes antimetastaticos. | |
| DE3677857D1 (de) | 2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |